Page last updated: 2024-09-03

omega-n-methylarginine and fluorobenzenes

omega-n-methylarginine has been researched along with fluorobenzenes in 4 studies

Compound Research Comparison

Studies (omega-n-methylarginine)	Trials (omega-n-methylarginine)	Recent Studies (post-2010) (omega-n-methylarginine)	Studies (fluorobenzenes)	Trials (fluorobenzenes)	Recent Studies (post-2010) (fluorobenzenes)
4,411	344	336	3,032	581	1,214

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ott, C; Schäufele, T; Schlaich, MP; Schmidt, BM; Schmieder, RE; Titze, SI	1
Bloch, W; Kelm, M; Kleinbongard, P; Ludolph, B; Schulz, R	1
Ott, C; Schlaich, MP; Schmieder, RE; Schneider, MP	1
Ott, C; Raff, U; Schmieder, RE; Schneider, MP; Titze, SI	1

Trials

3 trial(s) available for omega-n-methylarginine and fluorobenzenes

Article	Year
Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia. Atherosclerosis, 2008, Volume: 196, Issue:2 Topics: Adolescent; Adult; Aged; Blood Pressure; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Kidney; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Pyrimidines; Regional Blood Flow; Renal Circulation; Rosuvastatin Calcium; Sulfonamides; Time Factors	2008
Rosuvastatin improves pulse wave reflection by restoring endothelial function. Microvascular research, 2012, Volume: 84, Issue:1 Topics: Angiography; Blood Pressure; Cross-Over Studies; Elasticity; Endothelium, Vascular; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Microcirculation; Microvessels; Middle Aged; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Pulsatile Flow; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2012
25-hydroxyvitamin D insufficiency is associated with impaired renal endothelial function and both are improved with rosuvastatin treatment. Clinical research in cardiology : official journal of the German Cardiac Society, 2013, Volume: 102, Issue:4 Topics: Adult; Aged; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Pyrimidines; Regression Analysis; Rosuvastatin Calcium; Sulfonamides; Vitamin D; Vitamin D Deficiency	2013

Other Studies

1 other study(ies) available for omega-n-methylarginine and fluorobenzenes

Article	Year
Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity. Vascular health and risk management, 2007, Volume: 3, Issue:6 Topics: Enzyme Inhibitors; Erythrocyte Deformability; Erythrocytes; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Phosphorylation; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2007

Article

Year

Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity.

Vascular health and risk management, 2007, Volume: 3, Issue:6

Topics: Enzyme Inhibitors; Erythrocyte Deformability; Erythrocytes; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Phosphorylation; Pyrimidines; Rosuvastatin Calcium; Sulfonamides

2007